ASHLEY DIXON: Open Payments
NPI 1831820539 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 15 payments from 9 companies in 2025. Trend: 2023 $545 · 2024 $257 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $77 |
| PFIZER INC. | 3 | $64 |
| Abbott Laboratories | 2 | $37 |
| Lilly USA, LLC | 1 | $25 |
| ABBVIE INC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: CAPLYTA, ELIQUIS, FREESTYLE LIBRE 3, JARDIANCE, UBRELVY, Kerendia, TRELEGY ELLIPTA.
Industry payments across OK — which companies pay providers there.
